Işıl AYHAN, Ahter Tanay TAYYAR, İsmail DAĞ, Melike ALTINTAŞ, Hakan BİLGESOY, Betül YILMAZER

Serum follistatin-like-3 levels in the diagnosis of tubal ectopic pregnancy

Objective: Activin is necessary for maintaining normal pregnancy; follistatin and fol- listatin-like-3 (FSTL3) are known antagonists of activin. FSTL3 also has a role in the migration and invasion of trophoblasts. We aim to measure the value of serum FSTL3 levels in the diagnosis of tubal ectopic pregnancy. Material and Methods: Seventy-six pregnant women including 39 women with sur- gically confirmed tubal ectopic pregnancy and 37 healthy, singleton controls whose gestational ages were between 5 and 8 weeks. Serum FSTL3 levels were measured in both groups through ELISA. Receiver operator characteristic (ROC) curve analysis was performed for the prediction of tubal ectopic pregnancy using serum FSTL3. Results: Serum FSTL3 levels were significantly lower in the ectopic pregnancy group than in controls (p

PDF

___

. Bouyer J, Coste J, Fernandez H, Pouly JL, Job-Spira N. Sites of ectopic pregnancy: A 10 year population-based study of 1800 cases. Hum Re- prod 2002;17:3224–30.
2. Shi Y, Massagué J. Mechanisms of TGF-beta signaling from cell mem- brane to the nucleus. Cell 2003;113:685–700.
3. Rebbapragada A, Benchabane H, Wrana JL, Celeste AJ, Attisano L. Myostatin signals through a transforming growth factor beta-like signal- ing pathway to block adipogenesis. Mol Cell Biol 2003;23:7230–42.
4. Welt C, Sidis Y, Keutmann H, Schneyer A. Activins, inhibins, and folli- statins: From endocrinology to signaling. A paradigm for the new millen- nium. Exp Biol Med (Maywood) 2002;227:724–52.
5. Jones KL, de Kretser DM, Clarke IJ, Scheerlinck JP, Phillips DJ. Char- acterisation of the rapid release of activin A following acute lipopolysac- charide challenge in the ewe. J Endocrinol 2004;182:69–80.
6. Schneyer A, Sidis Y, Xia Y, Saito S, del Re E, Lin HY, et al. Differential ac- tions of follistatin and follistatin-like 3. Mol Cell Endocrinol 2004;225:25– 8.
7. Ciarmela P, Florio P, Toti P, Franchini A, Maguer-Satta V, Ginanneschi C, et al. Human placenta and fetal membranes express follistatin-related gene mRNA and protein. J Endocrinol Invest 2003;26:641–5.
8. Kumar TR. Too many follistatins: Racing inside and getting out of the cell. Endocrinology 2005;146:5048–51.
9. Tortoriello DV, Sidis Y, Holtzman DA, Holmes WE, Schneyer AL. Human follistatin-related protein: A structural homologue of follistatin with nucle- ar localization. Endocrinology 2001;142:3426–34.
10. Hill JJ, Davies MV, Pearson AA, Wang JH, Hewick RM, Wolfman NM, et al. The myostatin propeptide and the follistatin-related gene are in- hibitory binding proteins of myostatin in normal serum. J Biol Chem 2002;277:40735–41.
11. Refaat B. Role of activins in embryo implantation and diagnosis of ecto- pic pregnancy: A review. Reprod Biol Endocrinol 2014;12:116.
12. Shaw JL, Dey SK, Critchley HO, Horne AW. Current knowledge of the aetiology of human tubal ectopic pregnancy. Hum Reprod Update. 2010;16:432–44.
13. Berg CJ, Callaghan WM, Henderson Z, Syverson C. Pregnancy-re- lated mortality in the United States, 1998 to 2005. Obstet Gynecol 2011;117:1230.
14. Senapati S, Barnhart KT. Biomarkers for ectopic pregnancy and preg- nancy of unknown location. Fertil Steril 2013;99:1107–16.
15. Rausch ME, Sammel MD, Takacs P, Chung K, Shaunik A, Barnhart KT. Development of a multiple marker test for ectopic pregnancy. Obstet Gynecol 2011;117:573–82.
16. Wallace EM, Marjono B, Tyzack K, Tong S. First trimester levels of inhib- ins and activin A in normal and failing pregnancies. Clin Endocrinol (Oxf) 2004;60:484–90.
17. Bartholin L, Maguer-Satta V, Hayette S, Martel S, Gadoux M, Corbo L, et al. Transcription activation of FLRG and follistatin by activin A, through Smad proteins, participates in a negative feedback loop to modulate activin A function. Oncogene 2002;21:2227–35.
18. Xu Y, Xie J, Wan L, Wang M, Xu Y, Wang H, et al. Follistatin-like 3, an activin A binding protein, is involved in early pregnancy loss. Biomed Pharmacother 2020;121:109577.
19. de Kretser DM, Foulds LM, Hancock M, Robertson DM. Partial charac- terization of inhibin, activin, and follistatin in the term human placenta. J Clin Endocrinol Metab 1994;79:502–7.
20. Wånggren K, Stavreus-Evers A, Olsson C, Andersson E, Gemzell-Daniels- son K. Regulation of muscular contractions in the human Fallopian tube through prostaglandins and progestagens. Hum Reprod 2008;23:2359–68.
21. Li C, Zhang HY, Liang Y, Xia W, Zhu Q, Zhang D, et al. Effects of Levo- norgestrel and progesterone on Oviductal physiology in mammals. Re- prod Biol Endocrinol 2018;16:59.
22. Kaneko H. Subchapter 33C - Follistatin. In: Takei Y, Ando H, Tsutsui K, Hrsg, editors. Handbook of Hormones. San Diego: Academic Press; 2016. p. 298–300, e33C-1–e33C-2
23. Birkhahn RH, Gaeta TJ, Paraschiv D, Bove JJ, Suzuki T, Katoh H, et al. Serum levels of myoglobin, creatine phosphokinase, and smooth mus- cle heavy-chain myosin in patients with ectopic pregnancy. Ann Emerg Med 2001;38:628–32.
24. Guvendag Guven ES, Dilbaz S, Dilbaz B, Guven S, Sahin Ozdemir D, Haberal A. Serum biochemistry correlates with the size of tubal ectopic pregnancy on sonography. Ultrasound Obstet Gynecol 2006;28:826–30.
25. Karaman E, Çim N, Alkış İ, Yıldızhan R, Elçi G. Evaluation of mean platelet volume in unruptured ectopic pregnancy: A retrospective analy- sis. J Obstet Gynaecol 2016;36:622–5.
26. Chavhan PS, Patil BU, Gangane NM. Tubal ectopic pregnancy and vari- ation in platelet parameters: A six years study in rural population of cen- tral India. J Med Sci Clin Res 2017;5:15562–6.